LSX WORLD CONGRESS 2024

London, UK

29th April, 2024

Meet Axoltis Pharma’ CEO and CMO at LSX World Congress in London on 29th & 30th April 2024 to know more about NX210c, our very promizing drug candidate authorized to enter in Phase II trial in Amyotrophic Lateral Sclerosis.